Opponent process properties of self-administered cocaine

Neuroscience and Biobehavioral Reviews

Volumn 27, Issue 8, 2004, Pages 721-728

  Ettenberg, Aaron ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Conditioned place preference; Drug reinforcement; Drug self administration; Ethanol; Heroin; Reward; Runway; Speedball

Indexed keywords

ALCOHOL; COCAINE; DIAMORPHINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; AVERSIVE BEHAVIOR; AVOIDANCE BEHAVIOR; COCAINE DEPENDENCE; CONCEPT FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ABUSE; DRUG SELF ADMINISTRATION; INFORMATION PROCESSING; INSTRUMENTAL CONDITIONING; LOCOMOTION; MOTIVATION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REINFORCEMENT; RETREATMENT; REWARD; TASK PERFORMANCE; THEORY;

EID: 1042266418     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2003.11.009     Document Type: Conference Paper

References (93)

1. Anthony J.C., Tien A.Y., Petronis K.R. Epidemiologic evidence on cocaine use and panic attacks. Am J Epidemiol. 129:1989;543-549.
2. Anthony J.C., Warner L.A., Keesler R.C. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol. 2:(3):1994;244-268.
3. Baker T.B., Morse E., Sherman J.E. The motivation to use drugs: a psychobiological analysis of urges. Nebraska Symp Motivation. 34:1986;257-323.
4. Bardo M.T., Bevins R.A. Conditioned place preference: what does it add to, our preclinical understanding of drug reward. Psychopharmacology. 153:2000;31-43.
5. Blanchard R.J., Magee L., Veniegas R., Blanchard D.C. Alcohol and anxiety: ethopharmacological approaches. Prog Neuropsychopharmacol Biol Psychiatry. 17:(2):1993;171-182.
6. Blodgett H.C. The effect of the introduction of reward upon the maze performance in the rat. Univ California Pub Psychol. 4:1929;113-134.
7. Brady J.T., Sonne S., Randall C.L., Adinoff B., Malcolm R. Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend. 39:1995;69-71.
8. Brioni J.D., Cordoba N., Orsingher O.A. Decreased reactivity to the anticonflict effect of diazepam in perinatally undernourished rats. Behav Brain Res. 34:1989;159-162.
9. Broofkoff D., Raotondo M.F., Shaw L.M. Cocaethylene levels in patients who test positive for cocaine. Ann Emerg Med. 27:1996;316-320.
10. Carroll K.M., Rounsaville B.J., Bryant B.J. Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance. J Stud Alcohol. 54:1993;199-208.
11. Chausmer A.L., Ettenberg A. A role for D2, but not D1, dopamine receptors in the response-reinstating effects of food reinforcement. Pharmacol Biochem Behav. 57:1997;681-685.
12. Costello N.L., Carlson J.N., Glick S.D. Acute administration of diazepam and buspirone in rats trained on conflict schedules having different degrees of predictability. Pharmacol Biochem Behav. 40:1991;787-794.
13. Crespi L.P. Quantitative variation of incentive & performance in the white rat. Am J Psychol. 55:1942;467-517.
14. Cox B.J., Norton G.R., Swinson R.P., Endler N.S. Substance abuse and panic-related anxiety: a critical review. Behav Res Ther. 28:1990;385-393.
15. Czachowski C.L., Slawecki C.J., Grahame N.J., Thiele T.E., Katner S.N. Approaches to understanding the neurobiological regulation of ethanol self-administration: a young investigators forum. Alcohol Clin Exp Res. 25:2001;293-298.
16. Dalterio S.L., Wayner M.J., Geller I., Hartmann R.J. Ethanol and diazepam interactions on conflict behavior in rats. Alcohol. 5:1988;471-476.
17. Dean R.A., Christian C.D., Sample R.H.B., Borson W.F. Human liver cocaine esterases; ethanol-mediated formation of ethylcocaine. FASEB. 2736:1991;2735-2739.
18. DeVries A.C., Pert A. Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor. Psychopharmacology (Berlin). 137:1998;333-340.
19. Ettenberg A. Haloperidol prevents the reinstatement of amphetamine-rewarded runway responding in rats. Pharmacol Biochem Behav. 36:1990;635-638.
20. Ettenberg A., Camp C.H. Haloperidol induces a partial reinforcement extinction effect in rats: implications for a dopamine involvement in food reward. Pharmacol Biochem Behav. 25:1986;813-821.
21. Ettenberg A., Camp C.H. A partial reinforcement extinction effect in water-reinforced rats intermittently treated with haloperidol. Pharmacol Biochem Behav. 25:1986;1231-1235.
22. Ettenberg A., Geist T.D. An animal model for investigating the anxiogenic properties of self-administered cocaine. Psychopharmacology. 103:1991;455-461.
23. Ettenberg A., Geist T.D. Qualitative and quantitative differences in the operant runway behavior of cocaine and heroin reinforced rats. Pharmacol Biochem Behav. 44:1992;191-198.
24. Ettenberg A., Horvitz J.C. Pimozide prevents the response-reinstating effects of water reinforcement in rats. Pharmacol Biochem Behav. 37:1990;465-469.
25. Ettenberg A., MacConell L.A., Geist T.D. Effects of haloperidol in a response-reinstatement model of heroin relapse. Psychopharmacology. 124:1995;205-210.
26. Ettenberg A., Raven M.A., Danluck D.A., Necessary B.D. Evidence for opponent-process actions of intravenous cocaine. Pharmacol Biochem Behav. 64:1999;507-512.
27. Everitt B.J., Robbins T.W. Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour. Psychopharmacology. 153:2000;17-30.
28. Farre M., de la Torre R., Llorente M., Lamas X., Ugena B., Segura J., Cami J. Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther. 266:1993;1364-1373.
29. Fontana D.J., Commissaris R.J. Effects of cocaine on conflict behavior in the rat. Life Sci. 45:1989;819-827.
30. Gawin F.H., Kleber H.D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Arch Gen Psychiatry. 43:1986;107-113.
31. Geist T.D., Ettenberg A. A simple method for studying intravenous drug reinforcement in a runway. Pharmacol Biochem Behav. 36:1990;703-706.
32. Geist T.D., Wilson J., Ettenberg A. The anxiogenic properties of a benzodiazepine inverse agonist (FG-7142) as revealed using an operant runway paradigm. Soc Neurosci Abstr. 19:1993;373.
33. Geist T.D., Ettenberg A. Concurrent positive and negative goal box events produce runway behaviors comparable to those of cocaine-reinforced rats. Pharmacol Biochem Behav. 57:1997;145-150.
34. Geracioti T.D. Jr., Post R.M. Onset of panic disorder associated with rare use of cocaine. Biol Psychiatry. 29:1991;403-406.
35. Goeders N.E. Cocaine differentially affects benzodiazepine receptors in discrete regions of the rat brain: persistence and potential mechanism mediating these effects. J Pharmacol Exp Ther. 259:1991;574-581.
36. Goeders N.E. The HPA axis and cocaine reinforcement. Psychoneuroendocrinology. 27:2002;13-33.
37. Goldstein A. Heroin addiction: neurobiology, pharmacology, and policy. J Psychoactive Drugs. 23:(2):1991;123-133. April-June.
38. Goodwin R.D., Stayner D.A., Chinman M.J., Wu P., Tebes J.K., Davidson L. The relationship between anxiety and substance use disorders among individuals with severe affective disorders. Compr Psychiatry. 43:2002;245-252.
39. Grahame N.J., Chester J.A., Rodd-Henricks K., Li T.K., Lumeng L. Alcohol place preference conditioning in high- and low-alcohol preferring selected lines of mice. Pharmacol Biochem Behav. 68:2001;805-814.
40. Grant B.F., Harford T.C. Concurrent and simultaneous use of alcohol with cocaine: results of national survey. Drug Alcohol Depend. 25:1990;97-104.
41. Grathwohl C., Dadmarz M., Vogel W.H. Oral self-administration of ethanol and cocaine in rats. Pharmacology. 63:(3):2001;160-165.
42. Guzman D., Massion T., Ettenberg A. Heroin attenuates the anxiogenic effects of cocaine in a runway model of drug self-administration. Program No. 806.4.2002 Abstract Viewer/Itinerary Planner. 2002;Society for Neuroscience, Washington, DC. Online.
43. Higgins S.T., Rush C.R., Bickel W.K., Hughes J.R., Lynn M., Capeless M.A. Acute behavioral and cardiac effects of cocaine and alcohol combinations in humans. Psychopharmacology. 111:1993;285-294.
44. Horvitz J.C., Ettenberg A. Haloperidol blocks the response reinstating effects of food reward: a methodology for separating neuroleptic effects on reinforcement and motor processes. Pharmacol Biochem Behav. 31:1998;861-865.
45. Jatlow P., Elsworth J.D., Bradberry C.W., Winger G., Taylor J.R., Russel R., Roth R.H. Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci. 48:1991;1787-1794.
46. Knackstedt L.A., Ettenberg A. Ethanol consumption reduces the anxiogenic effects of IV cocaine in rats. Program No. 806.8.2002 Abstract Viewer/Itinerary Planner. 2002;Society for Neuroscience, Washington, DC. Online.
47. Knackstedt L.A., Samimi M.M., Ettenberg A. Evidence for opponent-process actions of intravenous cocaine and cocaethylene. Pharmacol Biochem Behav. 72:(4):2002;931-936.
48. Koob G.F. Animal models of craving for ethanol. Addiction. 95:(2):2000;S73-S81.
49. Koob G.F., Stinus L., LeMoal M., Bloom F.E. Opponent-process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci Biobehav Rev. 13:1989;135-140.
50. Koob G.F., Caine S.B., Parsons L., Markou A., Weiss F. Opponent process model and psychostimulant addiction. Pharmacol Biochem Behav. 57:1997;513-521.
51. Kosten T.A., Kosten T.R., Rounsaville B.J. Cocaine symptoms are predicted by familial psychopathology. NIDA Res Monograph. 105:1991;603-604.
52. Kozel N.J., Adams E.R. Cocaine use in America: epidemiological and clinical perspectives. NIDA Research Monograph 61. 1985;US Government Printing Office.
53. Logan F.A. Incentive: how the conditions of reinforcement affect the performance of rats. 1960;Yale University Press, New Haven, CT.
54. Lopez H.H., Olster D.H., Ettenberg A. Sexual motivation in the male rat: the role of primary incentives and copulatory experience. Hormones Behav. 36:1999;176-185.
55. Lopez H.H., Ettenberg A. Challenge during copulation prevents subsequent increase in male sexual motivation. Pharmacol Biochem Behav. 67:2000;387-393.
56. Lopez H.H., Ettenberg A. Dopamine antagonism attenuates the unconditioned incentive value of estrous female cues. Pharmacol Biochem Behav. 68:2001;411-416.
57. MacDonald A.B., Stewart S.H., Hutson R., Rhyno E., Loughlin H.L. The roles of alcohol and alcohol expectancy in the dampening of responses to hyperventilation among high anxiety sensitive young adults. Addict Behav. 26:2001;841-867.
58. Magura S., Rosenblum A. Modulating effect of alcohol use on cocaine use. Addict Behav. 25:2000;117-122.
59. Malow R.M., West J.A., Corrigan S.A., Pena J.M., Lott W.C. Cocaine and speedball users: differences in psychopathology. J Substance Abuse Treatmt. 9:1992;287-291.
60. Marshall C.E., Dadmarz M., Hofford J.M., Gottheil E., Vogel W.H. Self-administration of both ethanol and nicotine in rats. Pharmacology. 67:2003;143-149.
61. McCance E.F., Price L.H., Kostem T.R., Jatlow P.I. Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther. 274:1995;215-223.
62. McCance-Katz E.F., Price L.H., Dougle C.J., Koslen T.R., Black J.E., Jatlow P.I. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior and the role of cocaethylene. Psychopharmacology. 111:1993;39-46.
63. McFarland K., Ettenberg A. Haloperidol differentially affects reinforcement and motivational processes in rats running an alley for intravenous heroin. Psychopharmacology. 122:1995;346-350.
64. McFarland K., Ettenberg A. Haloperidol does not affect motivational processes in an operant runway model of food-seeking behavior. Behav Neurosci. 112:1998;630-635.
65. Middaugh L.D., Lee A.M., Bandy A.L. Ethanol reinforcement in nondeprived mice: effects of abstinence and naltrexone. Alcohol Clin Exp Res. 24:2000;1172-1179.
66. Miller N.E. Experimental studies of conflict. Hunt I.M.V. Personality and the behavior disorders. 1944;431-465 The Ronald Press Company, New York.
67. Moldow R.L., Fischman A.J. Cocaine induced secretion of ACTH, beta-endorphin and corticosterone. Peptides. 8:1987;819-822.
68. Paine T.A., Jackman S.L., Olmstead M.C. Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine. Behav Pharmacol. 13:2002;511-523.
69. Pan W.-J., Hedaya M.A. Cocaine and alcohol interactions in the rat: contributions of cocaine metabolites to the pharmacological effects. J Pharm Sci. 88:1999;468-476.
70. Perez-Reyes M., Jeffcoat A.R. Ethanol/cocaine interaction: cocaine and cocaethylene plasma concentrations and their relationship to subjective and cardiovascular effects. Life Sci. 51:1992;553-563.
71. Prather P.L., Lal H. Protracted withdrawal: sensitization of the anxiogenic response to cocaine in rats concurrently treated with ethanol. Neuropsychopharmacology. 6:1992;23-29.
72. Raven M.A., Necessary B.D., Danluck D.A., Ettenberg A. Comparison of the reinforcing and anxiogenic effects of intravenous cocaine and cocaethylene. Exp Clin Psychopharmacol. 8:2000;117-124.
73. Resnick R.B., Resnick E.B. Cocaine abuse and its treatment. Psychiatric Clinics North Am. 7:1984;713-728.
74. Rivier C., Vale W. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res. 422:1987;403-406.
75. Rogerio R., Takahashi R.N. Anxiogenic properties of cocaine in the rat evaluated with the elevated plus maze. Pharmacol Biochem Behav. 43:1992;631-633.
76. Rounsaville B.J., Anton S.F., Carroll K., Buddle D., Prusoff B.A., Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 48:1991;43-51.
77. Schechter M.D. Cocaethylene produces conditioned place preferences in rats. Pharmacol Biochem Behav. 51:1995;549-552.
78. Schechter M.D., Calcagnetti D.J. Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991. Neurosci Biobehav Rev. 17:1993;21-41.
79. Self D.W. Neural substrates of drug craving and relapse in addiction. Ann Med. 30:1998;379-389.
80. Shalev U., Grimm J.W., Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev. 94:2002;1-42.
81. Simon P., Dupuis R., Constentin J. Thigmotaxis as an index of anxiety in mice: influence of dopaminergic transmissions. Behav Brain Res. 61:1994;59-64.
82. Smith D.E. Cocaine-alcohol abuse: epidemiological, diagnostic and treatment considerations. J Psychoactive Drugs. 18:1986;117-129.
83. Solomon R.L. The opponent-process theory of acquired motivation: the costs of pleasure and the benefits of pain. Am Psychol. 35:1980;691-712.
84. Solomon R.L., Corbit J.D. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol Rev. 81:1974;119-145.
85. Spealman R.P. Behavior maintained by termination of schedules of self-administered cocaine. Science. 204:1979;1231-1233.
86. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol. 56:1998;613-672.
87. Walfish S., Massey R., Krone A. Anxiety and anger among abusers of different substances. Drug Alcohol Depend. 25:1990;253-256.
88. Washton A.M., Gold M.S. Chronic cocaine abuse: evidence for adverse effects on health and functioning. Psychiatr Ann. 14:1984;733-739.
89. Williamson S., Gossop M., Powis B., Griffiths P., Fountain J., Strong J. Adverse effects of stimulant drugs in a community sample of drug users. Drug Alcohol Depend. 44:1987;87-94.
90. Wilson G.T. Alcohol and anxiety. Behav Res Ther. 26:(5):1988;369-381.
91. Wise R.A. Opiate reward: sites and substrates. Neurosci Biobehav Rev. 13:1989;129-133.
92. Wise R.A. Brain reward circuitry: insights from unsensed incentives. Neuron. 36:2002;229-240.
93. Yang X.-M., Gorman A.L., Dunn A.J., Goeders N.E. Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies. Pharmacol Biochem Behav. 41:1992;643-650.